Computed tomographic evaluation of myocardial ischemia
- PMID: 32026226
- PMCID: PMC7186254
- DOI: 10.1007/s11604-020-00922-8
Computed tomographic evaluation of myocardial ischemia
Abstract
Myocardial ischemia is caused by a mismatch between myocardial oxygen consumption and oxygen delivery in coronary artery disease (CAD). Stratification and decision-making based on ischemia improves the prognosis in patients with CAD. Non-invasive tests used to evaluate myocardial ischemia include stress electrocardiography, echocardiography, single-photon emission computed tomography, and magnetic resonance imaging. Invasive fractional flow reserve is considered the reference standard for assessment of the hemodynamic significance of CAD. Computed tomography (CT) angiography has emerged as a first-line imaging modality for evaluation of CAD, particularly in the population at low to intermediate risk, because of its high negative predictive value; however, CT angiography does not provide information on the hemodynamic significance of stenosis, which lowers its specificity. Emerging techniques, e.g., CT perfusion and CT-fractional flow reserve, help to address this limitation of CT, by determining the hemodynamic significance of coronary artery stenosis. CT perfusion involves acquisition during the first pass of contrast medium through the myocardium following pharmacological stress. CT-fractional flow reserve uses computational fluid dynamics to model coronary flow, pressure, and resistance. In this article, we review these two functional CT techniques in the evaluation of myocardial ischemia, including their principles, technology, advantages, limitations, pitfalls, and the current evidence.
Keywords: Computed tomography; Coronary artery disease; Fractional flow reserve; Myocardial ischemia; Myocardial perfusion.
Conflict of interest statement
Yuki Tanabe declares that he has no conflict of interest. Akira Kurata declares that he has no conflict of interest. Takuya Matsuda declares that he has no conflict of interest. Kazuki Yoshida declares that he has no conflict of interest. Dhiraj Baruah is medical educator for Boehringer-Ingelheim pharmaceuticals, Inc. Teruhito Kido declares that he has no conflict of interest. Teruhito Mochizuki declares that he has no conflict of interest. Prabhakar Rajiah declares that he has no conflict of interest.
Figures
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
